C Vatier, S Christin-Maitre - Human Reproduction, 2024 - academic.oup.com
Polycystic ovary syndrome (PCOS) affects 6–20% of reproductive-aged women. It is associated with increased risks of metabolic syndrome, Type 2 diabetes, cardiovascular …
Introduction Non-diabetic women with polycystic ovarian syndrome (PCOS) often have abnormal insulin regulation. Calpain 10 (CALP10) is a biomarker of type 2 diabetes mellitus …
R Wu, C Gragnoli - Journal of Ovarian Research, 2024 - Springer
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder occurring in women of reproductive age. The disease is caused by a complex interplay of genetic and …
C Ma, L Yu, S Chen, X Wu, Y Yang, H Xie… - Biochemical and …, 2025 - Elsevier
Polycystic ovarian syndrome (PCOS) is a prevalent metabolic endocrine disorder in reproductive-aged women. This study aims to investigate the self-healing ability of PCOS …
N Ding, R Wang, P Wang, F Wang - Proteome Science, 2024 - Springer
Objective The study aimed to explore the role of metabolism-related proteins and their correlation with clinical data in predicting the prognosis of polycystic ovary syndrome …
R He, C Ma, L Yu, X Wu, H Xie, Y Yang, X Chen… - 2024 - researchsquare.com
Polycystic ovarian syndrome (PCOS) is a prevalent metabolic endocrine disorder in reproductive-age women. This study aims to investigate the self-healing ability of PCOS and …